$AKC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ABEONA THERAPEUTICS INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ABEONA THERAPEUTICS INC.. Get notifications about new insider transactions in ABEONA THERAPEUTICS INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 18 2019 | AKC | ABEONA THERAPEUTIC ... | CARR EDWARD | Chief Accounting Of ... | Option Exercise | A | 8.54 | 35,000 | 298,900 | 35,000 | |
Apr 12 2019 | AKC | ABEONA THERAPEUTIC ... | Buono Stefano | Director | Buy | P | 7.91 | 49,020 | 387,979 | 70,000 | 21 K to 70 K (+233.65 %) |
Apr 12 2019 | AKC | ABEONA THERAPEUTIC ... | Buono Stefano | Director | Buy | P | 7.54 | 20,980 | 158,271 | 20,980 | 0 to 21 K |
Apr 11 2019 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Executive Chairman | Option Exercise | A | 7.24 | 120,000 | 868,800 | 120,000 | |
Apr 11 2019 | AKC | ABEONA THERAPEUTIC ... | Miller Timothy J | See Remarks | Option Exercise | A | 7.24 | 72,000 | 521,280 | 72,000 | |
Apr 11 2019 | AKC | ABEONA THERAPEUTIC ... | CARR EDWARD | Chief Accounting Of ... | Option Exercise | A | 7.24 | 10,000 | 72,400 | 10,000 | |
Apr 11 2019 | AKC | ABEONA THERAPEUTIC ... | Siffert Joao MD | Chief Executive Off ... | Option Exercise | A | 7.24 | 100,000 | 724,000 | 100,000 | |
Apr 11 2019 | AKC | ABEONA THERAPEUTIC ... | Silverstein Christine Berni | Chief Financial Off ... | Option Exercise | A | 7.24 | 80,000 | 579,200 | 80,000 | |
Apr 10 2019 | AKC | ABEONA THERAPEUTIC ... | Howell Stephen B. | Director | Buy | P | 7.77 | 4,000 | 31,080 | 79,494 | 75.5 K to 79.5 K (+5.30 %) |
May 23 2018 | AKC | ABEONA THERAPEUTIC ... | Buono Stefano | Director | Option Exercise | A | 16.02 | 30,000 | 480,600 | 30,000 | |
May 23 2018 | AKC | ABEONA THERAPEUTIC ... | Van Duyne Richard B | Director | Option Exercise | A | 16.02 | 30,000 | 480,600 | 30,000 | |
Apr 02 2018 | AKC | ABEONA THERAPEUTIC ... | Thiel Carsten | Chief Executive Off ... | Option Exercise | A | 13.65 | 262,500 | 3,583,125 | 262,500 | |
Apr 02 2018 | AKC | ABEONA THERAPEUTIC ... | Thiel Carsten | Chief Executive Off ... | Option Exercise | A | 13.65 | 87,500 | 1,194,375 | 87,500 | |
Dec 18 2017 | AKC | ABEONA THERAPEUTIC ... | THOMPSON STEPHEN B | Sr VP Finance | Option Exercise | A | 16.00 | 18,750 | 300,000 | 18,750 | |
Dec 18 2017 | AKC | ABEONA THERAPEUTIC ... | THOMPSON STEPHEN B | Sr VP Finance | Option Exercise | A | 16.00 | 6,250 | 100,000 | 6,250 | |
Dec 18 2017 | AKC | ABEONA THERAPEUTIC ... | Alvino Mark | Director | Option Exercise | A | 16.00 | 30,000 | 480,000 | 30,000 | |
Dec 18 2017 | AKC | ABEONA THERAPEUTIC ... | Wider Todd | Director | Option Exercise | A | 16.00 | 30,000 | 480,000 | 30,000 | |
Dec 18 2017 | AKC | ABEONA THERAPEUTIC ... | Miller Timothy J | President & CEO | Option Exercise | A | 16.00 | 67,500 | 1,080,000 | 67,500 | |
Dec 18 2017 | AKC | ABEONA THERAPEUTIC ... | Miller Timothy J | President & CEO | Option Exercise | A | 16.00 | 22,500 | 360,000 | 22,500 | |
Dec 18 2017 | AKC | ABEONA THERAPEUTIC ... | Jeffrey B Davis | COO | Option Exercise | A | 16.00 | 60,000 | 960,000 | 60,000 | |
Dec 18 2017 | AKC | ABEONA THERAPEUTIC ... | Jeffrey B Davis | COO | Option Exercise | A | 16.00 | 20,000 | 320,000 | 20,000 | |
Dec 18 2017 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Executive Chairman | Option Exercise | A | 16.00 | 90,000 | 1,440,000 | 90,000 | |
Dec 18 2017 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Executive Chairman | Option Exercise | A | 16.00 | 30,000 | 480,000 | 30,000 | |
Dec 15 2016 | AKC | ABEONA THERAPEUTIC ... | THOMPSON STEPHEN B | VP Finance-Chief Ac ... | Option Exercise | A | 4.45 | 18,750 | 83,438 | 25,000 | |
Dec 15 2016 | AKC | ABEONA THERAPEUTIC ... | THOMPSON STEPHEN B | VP Finance-Chief Ac ... | Option Exercise | A | 4.45 | 6,250 | 27,813 | 6,250 | |
Dec 15 2016 | AKC | ABEONA THERAPEUTIC ... | Wider Todd | Director | Option Exercise | A | 4.45 | 50,000 | 222,500 | 50,000 | |
Dec 15 2016 | AKC | ABEONA THERAPEUTIC ... | Alvino Mark | Director | Option Exercise | A | 4.45 | 50,000 | 222,500 | 50,000 | |
Dec 15 2016 | AKC | ABEONA THERAPEUTIC ... | Ahn Mark J | Director | Option Exercise | A | 4.45 | 150,000 | 667,500 | 150,000 | |
Dec 15 2016 | AKC | ABEONA THERAPEUTIC ... | Jeffrey B Davis | Chief Operating Off ... | Option Exercise | A | 4.45 | 112,500 | 500,625 | 150,000 | |
Dec 15 2016 | AKC | ABEONA THERAPEUTIC ... | Jeffrey B Davis | Chief Operating Off ... | Option Exercise | A | 4.45 | 37,500 | 166,875 | 37,500 | |
Dec 15 2016 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Executive Chairman | Option Exercise | A | 4.45 | 150,000 | 667,500 | 200,000 | |
Dec 15 2016 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Executive Chairman | Option Exercise | A | 4.45 | 50,000 | 222,500 | 50,000 | |
Nov 09 2016 | AKC | ABEONA THERAPEUTIC ... | Wider Todd | Director | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
Nov 09 2016 | AKC | ABEONA THERAPEUTIC ... | Ahn Mark J | Director | Option Exercise | M | 2.31 | 150,000 | 346,500 | 0 | |
Nov 09 2016 | AKC | ABEONA THERAPEUTIC ... | Ahn Mark J | Director | Buy | M | 2.31 | 150,000 | 346,500 | 493,182 | 343.2 K to 493.2 K (+43.71 %) |
Sep 28 2016 | AKC | ABEONA THERAPEUTIC ... | Wider Todd | Director | Buy | P | 5.48 | 5,000 | 27,400 | 75,000 | 70 K to 75 K (+7.14 %) |
Feb 16 2016 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Executive Chairman | Option Exercise | A | 2.31 | 150,000 | 346,500 | 200,000 | |
Feb 16 2016 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Executive Chairman | Option Exercise | A | 2.31 | 50,000 | 115,500 | 50,000 | |
Feb 16 2016 | AKC | ABEONA THERAPEUTIC ... | Jeffrey B Davis | Chief Operating Off ... | Option Exercise | A | 2.31 | 112,500 | 259,875 | 150,000 | |
Feb 16 2016 | AKC | ABEONA THERAPEUTIC ... | Jeffrey B Davis | Chief Operating Off ... | Option Exercise | A | 2.31 | 37,500 | 86,625 | 37,500 | |
Feb 16 2016 | AKC | ABEONA THERAPEUTIC ... | THOMPSON STEPHEN B | VP-Finance Chief Ac ... | Option Exercise | A | 2.31 | 56,250 | 129,938 | 75,000 | |
Feb 16 2016 | AKC | ABEONA THERAPEUTIC ... | THOMPSON STEPHEN B | VP-Finance Chief Ac ... | Option Exercise | A | 2.31 | 18,750 | 43,313 | 18,750 | |
Feb 16 2016 | AKC | ABEONA THERAPEUTIC ... | Wider Todd | Director | Option Exercise | A | 2.31 | 50,000 | 115,500 | 50,000 | |
Feb 16 2016 | AKC | ABEONA THERAPEUTIC ... | Alvino Mark | Director | Option Exercise | A | 2.31 | 50,000 | 115,500 | 50,000 | |
Feb 16 2016 | AKC | ABEONA THERAPEUTIC ... | Ahn Mark J | Director | Option Exercise | A | 2.31 | 150,000 | 346,500 | 150,000 | |
Aug 03 2015 | AKC | ABEONA THERAPEUTIC ... | Wider Todd | Director | Buy | P | 5.50 | 20,000 | 110,000 | 70,000 | 50 K to 70 K (+40.00 %) |
Aug 03 2015 | AKC | ABEONA THERAPEUTIC ... | Ahn Mark J | Director | Buy | P | 5.50 | 18,182 | 100,001 | 343,182 | 325 K to 343.2 K (+5.59 %) |
Jun 19 2015 | AKC | ABEONA THERAPEUTIC ... | Wider Todd | Director | Option Exercise | A | 7.34 | 100,000 | 734,000 | 100,000 | |
Jun 19 2015 | AKC | ABEONA THERAPEUTIC ... | Wider Todd | Director | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
May 13 2015 | AKC | ABEONA THERAPEUTIC ... | Alvino Mark | Director | Option Exercise | A | 75,000.00 | 75,000 | 5,625,000,000 | 87,120 | |
May 13 2015 | AKC | ABEONA THERAPEUTIC ... | Alvino Mark | Director | Grant | A | 7.34 | 75,000 | 550,500 | 75,000 | 0 to 75 K |
May 13 2015 | AKC | ABEONA THERAPEUTIC ... | Ahn Mark J | Director | Option Exercise | A | 7.34 | 100,000 | 734,000 | 115,320 | |
May 13 2015 | AKC | ABEONA THERAPEUTIC ... | Ahn Mark J | Director | Grant | A | 7.34 | 300,000 | 2,202,000 | 325,000 | 25 K to 325 K (+1,200.00 %) |
May 13 2015 | AKC | ABEONA THERAPEUTIC ... | THOMPSON STEPHEN B | Vice President Fina ... | Option Exercise | A | 7.34 | 75,000 | 550,500 | 90,000 | |
May 13 2015 | AKC | ABEONA THERAPEUTIC ... | THOMPSON STEPHEN B | Vice President Fina ... | Grant | A | 7.34 | 75,000 | 550,500 | 84,896 | 9.9 K to 84.9 K (+757.88 %) |
May 13 2015 | AKC | ABEONA THERAPEUTIC ... | Jeffrey B Davis | Chief Operating Off ... | Option Exercise | A | 7.34 | 100,000 | 734,000 | 140,500 | |
May 13 2015 | AKC | ABEONA THERAPEUTIC ... | Jeffrey B Davis | Chief Operating Off ... | Grant | A | 7.34 | 300,000 | 2,202,000 | 300,000 | 0 to 300 K |
May 13 2015 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Executive Chairman | Option Exercise | A | 7.34 | 125,000 | 917,500 | 205,000 | |
May 13 2015 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Executive Chairman | Grant | A | 7.34 | 375,000 | 2,752,500 | 375,000 | 0 to 375 K |
Jan 26 2015 | AKC | ABEONA THERAPEUTIC ... | Ahn Mark J | Director | Option Exercise | P | 5.00 | 25,000 | 125,000 | 25,000 | |
Jan 26 2015 | AKC | ABEONA THERAPEUTIC ... | Ahn Mark J | Director | Buy | P | 4.00 | 25,000 | 100,000 | 25,000 | 0 to 25 K |
Dec 29 2014 | AKC | ABEONA THERAPEUTIC ... | Jeffrey B Davis | Director | Option Exercise | C | 4.00 | 238 | 952 | 0 | |
Dec 29 2014 | AKC | ABEONA THERAPEUTIC ... | Jeffrey B Davis | Director | Option Exercise | P | 5.00 | 62,500 | 312,500 | 62,500 | |
Dec 29 2014 | AKC | ABEONA THERAPEUTIC ... | Jeffrey B Davis | Director | Buy | J | 4.00 | 300,852 | 1,203,408 | 963,511 | 662.7 K to 963.5 K (+45.40 %) |
Dec 29 2014 | AKC | ABEONA THERAPEUTIC ... | Jeffrey B Davis | Director | Buy | J | 4.00 | 594,801 | 2,379,204 | 662,659 | 67.9 K to 662.7 K (+876.54 %) |
Dec 29 2014 | AKC | ABEONA THERAPEUTIC ... | Jeffrey B Davis | Director | Buy | P | 4.00 | 62,500 | 250,000 | 67,858 | 5.4 K to 67.9 K (+1,166.48 %) |
Dec 29 2014 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Director | Option Exercise | J | 4.00 | 139 | 556 | 0 | |
Dec 29 2014 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Director | Option Exercise | J | 4.00 | 861 | 3,444 | 0 | |
Dec 29 2014 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Director | Option Exercise | C | 4.00 | 154 | 616 | 0 | |
Dec 29 2014 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Director | Option Exercise | C | 4.00 | 1,969 | 7,876 | 0 | |
Dec 29 2014 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Director | Option Exercise | P | 5.00 | 250,000 | 1,250,000 | 702,195 | |
Dec 29 2014 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Director | Buy | J | 4.00 | 216,718 | 866,872 | 1,364,195 | 1.1 M to 1.4 M (+18.89 %) |
Dec 29 2014 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Director | Buy | J | 4.00 | 1,703,362 | 6,813,448 | 12,080,463 | 10.4 M to 12.1 M (+16.41 %) |
Dec 29 2014 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Director | Buy | J | 4.00 | 693,051 | 2,772,204 | 1,147,477 | 454.4 K to 1.1 M (+152.51 %) |
Dec 29 2014 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Director | Buy | J | 4.00 | 4,306,950 | 17,227,800 | 10,377,102 | 6.1 M to 10.4 M (+70.95 %) |
Dec 29 2014 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Director | Buy | C | 4.00 | 65,280 | 261,120 | 454,427 | 389.1 K to 454.4 K (+16.78 %) |
Dec 29 2014 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Director | Buy | C | 4.00 | 831,836 | 3,327,344 | 6,070,152 | 5.2 M to 6.1 M (+15.88 %) |
Dec 29 2014 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Director | Buy | C | 4.00 | 385,725 | 1,542,900 | 389,147 | 3.4 K to 389.1 K (+11,271.92 %) |
Dec 29 2014 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Director | Buy | C | 4.00 | 4,922,102 | 19,688,408 | 5,238,316 | 316.2 K to 5.2 M (+1,556.57 %) |
Dec 29 2014 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Director | Buy | P | 4.00 | 250,000 | 1,000,000 | 316,214 | 66.2 K to 316.2 K (+377.56 %) |
Mar 11 2014 | AKC | ABEONA THERAPEUTIC ... | Alvino Mark | Director | Option Exercise | A | 0.37 | 375,000 | 138,750 | 606,000 | |
Mar 11 2014 | AKC | ABEONA THERAPEUTIC ... | Alvino Mark | Director | Option Exercise | A | 0.37 | 125,000 | 46,250 | 231,000 | |
Mar 11 2014 | AKC | ABEONA THERAPEUTIC ... | Jeffrey B Davis | CEO | Option Exercise | A | 0.37 | 1,500,000 | 555,000 | 2,025,000 | |
Mar 11 2014 | AKC | ABEONA THERAPEUTIC ... | Jeffrey B Davis | CEO | Option Exercise | A | 0.37 | 500,000 | 185,000 | 525,000 | |
Mar 11 2014 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Director | Option Exercise | A | 0.37 | 3,000,000 | 1,110,000 | 4,000,000 | |
Mar 11 2014 | AKC | ABEONA THERAPEUTIC ... | Rouhandeh Steven H | Director | Option Exercise | A | 0.37 | 1,000,000 | 370,000 | 1,000,000 | |
Dec 20 2012 | AKC | ABEONA THERAPEUTIC ... | SCO CAPITAL PARTNERS LLC | 10% Owner | Option Exercise | G | 0.50 | 1,366,202 | 683,101 | 2,772,202 | |
Dec 20 2012 | AKC | ABEONA THERAPEUTIC ... | SCO CAPITAL PARTNERS LLC | 10% Owner | Option Exercise | G | 0.50 | 1,366,202 | 683,101 | 17,227,798 | |
Dec 20 2012 | AKC | ABEONA THERAPEUTIC ... | SCO CAPITAL PARTNERS LLC | 10% Owner | Option Exercise | G | 0.50 | 68 | 34 | 139 | |
Dec 20 2012 | AKC | ABEONA THERAPEUTIC ... | SCO CAPITAL PARTNERS LLC | 10% Owner | Option Exercise | G | 0.50 | 68 | 34 | 861 | |
Oct 26 2012 | AKC | ABEONA THERAPEUTIC ... | SCO CAPITAL PARTNERS LLC | 10% Owner | Option Exercise | P | 0.50 | 1,406,000 | 703,000 | 1,406,000 | |
Oct 26 2012 | AKC | ABEONA THERAPEUTIC ... | SCO CAPITAL PARTNERS LLC | 10% Owner | Option Exercise | P | 0.50 | 18,594,000 | 9,297,000 | 18,594,000 | |
Oct 26 2012 | AKC | ABEONA THERAPEUTIC ... | SCO CAPITAL PARTNERS LLC | 10% Owner | Option Exercise | P | 0.50 | 70 | 35 | 70 | |
Oct 26 2012 | AKC | ABEONA THERAPEUTIC ... | SCO CAPITAL PARTNERS LLC | 10% Owner | Option Exercise | P | 0.50 | 930 | 465 | 930 | |
Jun 29 2012 | AKC | ABEONA THERAPEUTIC ... | Ayer Capital Management, LP | 10% Owner | Sell | S | 0.55 | 179,157 | 99,074 | 2,413,163 | 2.6 M to 2.4 M (-6.91 %) |
Jun 29 2012 | AKC | ABEONA THERAPEUTIC ... | Ayer Capital Management, LP | 10% Owner | Sell | S | 0.68 | 25,000 | 16,875 | 2,592,320 | 2.6 M to 2.6 M (-0.96 %) |
May 29 2012 | AKC | ABEONA THERAPEUTIC ... | THOMPSON STEPHEN B | CFO | Option Exercise | E | 18.65 | 6,000 | 111,900 | 437,000 | |
May 29 2012 | AKC | ABEONA THERAPEUTIC ... | THOMPSON STEPHEN B | CFO | Option Exercise | A | 0.61 | 50,000 | 30,500 | 443,000 | |
May 29 2012 | AKC | ABEONA THERAPEUTIC ... | NOWOTNIK DAVID P | Sr. VP R&D | Option Exercise | E | 18.65 | 10,000 | 186,500 | 545,000 | |
May 29 2012 | AKC | ABEONA THERAPEUTIC ... | NOWOTNIK DAVID P | Sr. VP R&D | Option Exercise | A | 0.61 | 50,000 | 30,500 | 555,000 | |
May 16 2012 | AKC | ABEONA THERAPEUTIC ... | Ayer Capital Management, LP | 10% Owner | Sell | S | 0.85 | 1,000 | 850 | 2,757,620 | 2.8 M to 2.8 M (-0.04 %) |
May 16 2012 | AKC | ABEONA THERAPEUTIC ... | Ayer Capital Management, LP | 10% Owner | Sell | S | 0.67 | 140,300 | 94,001 | 2,617,320 | 2.8 M to 2.6 M (-5.09 %) |
Jan 26 2012 | AKC | ABEONA THERAPEUTIC ... | THOMPSON STEPHEN B | CFO | Grant | A | 1.36 | 15,000 | 20,400 | 18,521 | 3.5 K to 18.5 K (+426.02 %) |
Jan 26 2012 | AKC | ABEONA THERAPEUTIC ... | NOWOTNIK DAVID P | Sr. VP R&D | Grant | A | 1.36 | 15,000 | 20,400 | 20,116 | 5.1 K to 20.1 K (+293.20 %) |
Jun 01 2011 | AKC | ABEONA THERAPEUTIC ... | NOWOTNIK DAVID P | Sr. VP R&D | Option Exercise | A | 2.27 | 37,500 | 85,125 | 505,000 | |
Jun 01 2011 | AKC | ABEONA THERAPEUTIC ... | NOWOTNIK DAVID P | Sr. VP R&D | Option Exercise | A | 2.27 | 12,500 | 28,375 | 467,500 | |
Jun 01 2011 | AKC | ABEONA THERAPEUTIC ... | THOMPSON STEPHEN B | CFO | Option Exercise | A | 2.27 | 37,500 | 85,125 | 393,000 | |
Jun 01 2011 | AKC | ABEONA THERAPEUTIC ... | THOMPSON STEPHEN B | CFO | Option Exercise | A | 2.27 | 12,500 | 28,375 | 355,500 | |
May 28 2010 | AKC | ABEONA THERAPEUTIC ... | THOMPSON STEPHEN B | CFO | Option Exercise | A | 2.45 | 100,000 | 245,000 | 343,000 | |
May 28 2010 | AKC | ABEONA THERAPEUTIC ... | NOWOTNIK DAVID P | Sr VP R&D | Option Exercise | A | 2.79 | 200,000 | 558,000 | 455,000 | |
Nov 02 2009 | AKC | ABEONA THERAPEUTIC ... | LUCI DAVID P | Director | Option Exercise | A | 1.38 | 20,000 | 27,600 | 88,500 | |
Nov 02 2009 | AKC | ABEONA THERAPEUTIC ... | LUCI DAVID P | Director | Option Exercise | A | 1.38 | 25,000 | 34,500 | 68,500 | |
Nov 02 2009 | AKC | ABEONA THERAPEUTIC ... | LUCI DAVID P | Director | Option Exercise | A | 2.90 | 6,000 | 17,400 | 43,500 | |
Nov 02 2009 | AKC | ABEONA THERAPEUTIC ... | LUCI DAVID P | Director | Option Exercise | P | 3.50 | 4,167 | 14,585 | 37,500 | |
Nov 02 2009 | AKC | ABEONA THERAPEUTIC ... | LUCI DAVID P | Director | Option Exercise | P | 3.00 | 3 | 9 | 33,333 | |
Nov 02 2009 | AKC | ABEONA THERAPEUTIC ... | LUCI DAVID P | Director | Grant | A | 0.00 | 200,000 | 0 | 263,217 | 63.2 K to 263.2 K (+316.37 %) |
Nov 02 2009 | AKC | ABEONA THERAPEUTIC ... | LUCI DAVID P | Director | Buy | J | 0.00 | 2,259 | 0 | 63,217 | 61 K to 63.2 K (+3.71 %) |
Nov 02 2009 | AKC | ABEONA THERAPEUTIC ... | LUCI DAVID P | Director | Buy | J | 1.15 | 60,000 | 69,000 | 60,958 | 958 to 61 K (+6,263.05 %) |
Nov 02 2009 | AKC | ABEONA THERAPEUTIC ... | LUCI DAVID P | Director | Buy | J | 0.96 | 785 | 754 | 958 | 173 to 958 (+453.76 %) |
Nov 02 2009 | AKC | ABEONA THERAPEUTIC ... | LUCI DAVID P | Director | Buy | J | 2.75 | 173 | 476 | 173 | 0 to 173 |
Nov 02 2009 | AKC | ABEONA THERAPEUTIC ... | THOMPSON STEPHEN B | Chief Financial Off ... | Option Exercise | A | 1.38 | 75,000 | 103,500 | 252,000 | |
Nov 02 2009 | AKC | ABEONA THERAPEUTIC ... | NOWOTNIK DAVID P | Sr Vice President R ... | Option Exercise | A | 1.38 | 75,000 | 103,500 | 265,000 | |
Jun 19 2009 | AKC | ABEONA THERAPEUTIC ... | SCO CAPITAL PARTNERS LLC | 10% Owner | Buy | J | 0.00 | 1,510,926 | 0 | 3,252,142 | 1.7 M to 3.3 M (+86.77 %) |
Jun 19 2009 | AKC | ABEONA THERAPEUTIC ... | SCO CAPITAL PARTNERS LLC | 10% Owner | Buy | J | 0.00 | 101,541 | 0 | 171,085 | 69.5 K to 171.1 K (+146.01 %) |
Jun 19 2009 | AKC | ABEONA THERAPEUTIC ... | SCO CAPITAL PARTNERS LLC | 10% Owner | Buy | J | 0.00 | 24,232 | 0 | 35,679 | 11.4 K to 35.7 K (+211.69 %) |
Feb 06 2009 | AKC | ABEONA THERAPEUTIC ... | SCO CAPITAL PARTNERS LLC | 10% Owner | Buy | J | 0.00 | 69,544 | 0 | 69,544 | 0 to 69.5 K |
Feb 06 2009 | AKC | ABEONA THERAPEUTIC ... | SCO CAPITAL PARTNERS LLC | 10% Owner | Buy | J | 0.00 | 846,622 | 0 | 1,634,424 | 787.8 K to 1.6 M (+107.47 %) |
Feb 06 2009 | AKC | ABEONA THERAPEUTIC ... | Jeffrey B Davis | Chief Executive Off ... | Buy | J | 0.96 | 74,709 | 71,571 | 173,250 | 98.5 K to 173.3 K (+75.82 %) |
Feb 06 2009 | AKC | ABEONA THERAPEUTIC ... | Jeffrey B Davis | Chief Executive Off ... | Buy | J | 2.75 | 24,897 | 68,467 | 173,250 | 148.4 K to 173.3 K (+16.78 %) |
Feb 06 2009 | AKC | ABEONA THERAPEUTIC ... | Jeffrey B Davis | Chief Executive Off ... | Buy | J | 3.00 | 5,950 | 17,850 | 173,250 | 167.3 K to 173.3 K (+3.56 %) |
Dec 19 2008 | AKC | ABEONA THERAPEUTIC ... | SCO CAPITAL PARTNERS L P | 10% Owner | Option Exercise | J | 3.50 | 333,333 | 1,166,666 | 333,333 | |
Dec 19 2008 | AKC | ABEONA THERAPEUTIC ... | SCO CAPITAL PARTNERS L P | 10% Owner | Option Exercise | J | 3.50 | 333,333 | 1,166,666 | 0 | |
Dec 19 2008 | AKC | ABEONA THERAPEUTIC ... | SCO CAPITAL PARTNERS L P | 10% Owner | Option Exercise | J | 3.00 | 200 | 600 | 1,969 | |
Dec 19 2008 | AKC | ABEONA THERAPEUTIC ... | SCO CAPITAL PARTNERS L P | 10% Owner | Option Exercise | J | 3.00 | 200 | 600 | 0 | |
Sep 22 2008 | AKC | ABEONA THERAPEUTIC ... | Jeffrey B Davis | Chief Executive Off ... | Option Exercise | G | 3.50 | 50,000 | 175,000 | 290,909 | |
Jun 10 2008 | AKC | ABEONA THERAPEUTIC ... | FEINBERG LARRY N | 10% Owner | Option Exercise | S | 0.00 | 119,811 | 0 | 119,811 | |
Jun 10 2008 | AKC | ABEONA THERAPEUTIC ... | FEINBERG LARRY N | 10% Owner | Option Exercise | P | 0.00 | 119,811 | 0 | 119,811 | |
Jun 10 2008 | AKC | ABEONA THERAPEUTIC ... | FEINBERG LARRY N | 10% Owner | Option Exercise | S | 0.00 | 72 | 0 | 72 | |
Jun 10 2008 | AKC | ABEONA THERAPEUTIC ... | FEINBERG LARRY N | 10% Owner | Option Exercise | P | 0.00 | 72 | 0 | 72 | |
Jun 10 2008 | AKC | ABEONA THERAPEUTIC ... | FEINBERG LARRY N | 10% Owner | Option Exercise | J | 0.00 | 728,850 | 0 | 728,850 | |
Jun 10 2008 | AKC | ABEONA THERAPEUTIC ... | FEINBERG LARRY N | 10% Owner | Option Exercise | J | 0.00 | 437 | 0 | 437 | |
Jun 10 2008 | AKC | ABEONA THERAPEUTIC ... | FEINBERG LARRY N | 10% Owner | Sell | S | 3.15 | 29,736 | 93,668 | 296,483 | 326.2 K to 296.5 K (-9.12 %) |
Jun 10 2008 | AKC | ABEONA THERAPEUTIC ... | FEINBERG LARRY N | 10% Owner | Buy | P | 3.15 | 29,736 | 93,668 | 296,483 | 266.7 K to 296.5 K (+11.15 %) |
Jun 10 2008 | AKC | ABEONA THERAPEUTIC ... | FEINBERG LARRY N | 10% Owner | Sell | S | 4.35 | 2,040 | 8,874 | 296,483 | 298.5 K to 296.5 K (-0.68 %) |
Jun 10 2008 | AKC | ABEONA THERAPEUTIC ... | FEINBERG LARRY N | 10% Owner | Sell | S | 4.36 | 4,000 | 17,425 | 298,523 | 302.5 K to 298.5 K (-1.32 %) |
Jun 10 2008 | AKC | ABEONA THERAPEUTIC ... | FEINBERG LARRY N | 10% Owner | Buy | P | 5.17 | 60,000 | 310,200 | 302,523 | 242.5 K to 302.5 K (+24.74 %) |
Jun 10 2008 | AKC | ABEONA THERAPEUTIC ... | FEINBERG LARRY N | 10% Owner | Sell | S | 5.17 | 20,000 | 103,400 | 302,523 | 322.5 K to 302.5 K (-6.20 %) |
Jun 10 2008 | AKC | ABEONA THERAPEUTIC ... | FEINBERG LARRY N | 10% Owner | Sell | S | 5.17 | 40,000 | 206,800 | 302,523 | 342.5 K to 302.5 K (-11.68 %) |
Jun 10 2008 | AKC | ABEONA THERAPEUTIC ... | FEINBERG LARRY N | 10% Owner | Sell | S | 7.13 | 1,200 | 8,550 | 302,523 | 303.7 K to 302.5 K (-0.40 %) |
Jun 10 2008 | AKC | ABEONA THERAPEUTIC ... | FEINBERG LARRY N | 10% Owner | Sell | S | 7.10 | 4,500 | 31,950 | 302,523 | 307 K to 302.5 K (-1.47 %) |